HM Payson & Co’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-339
Closed -$6K 1182
2021
Q4
$6K Buy
+339
New +$6.58K ﹤0.01% 940
2021
Q2
Sell
-732
Closed -$29K 1200
2021
Q1
$29K Hold
732
﹤0.01% 699
2020
Q4
$32K Buy
732
+305
+71% +$10.4K ﹤0.01% 698
2020
Q3
$12K Buy
+427
New +$13.5K ﹤0.01% 816

Other funds holding ONEM

HM Payson & Co's ONEM Position: Q1 2022 in Review

HM Payson & Co sold out of 1Life Healthcare (ONEM) in Q1 2022, closing a stake of 339 shares — an estimated $6K sold.

HM Payson & Co first reported a position in ONEM in Q3 2020 and held it in 4 quarters. The position peaked at $32K in Q4 2020. 189 funds tracked by Wall St. Rank hold ONEM as of Q1 2022.

  • HM Payson & Co reported no remaining 1Life Healthcare position as of Q1 2022 after selling out during the quarter.
  • HM Payson & Co sold 339 1Life Healthcare shares in Q1 2022, an estimated $6K.
  • HM Payson & Co first reported a position in 1Life Healthcare in Q3 2020 and held it in 4 quarters.
  • HM Payson & Co's 1Life Healthcare position peaked at $32K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2022.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.